Support is growing for increased collaboration between pharmaceutical companies and patients in research processes worldwide, according to a new report by healthcare intelligence company GBI Research.
Previous experimental work had raised theoretical concerns about the risk of cancer, since ARBs play a role in regulating angiogenesis, cell proliferation, and tumour progression.